$Cassava Sciences (SAVA.US)$ It is unethical and inexcusable...
$Cassava Sciences (SAVA.US)$ It is unethical and inexcusable what the shorts have done by delaying trials, trying to stop with citizens petition , writing FUD articles and manipulating stock price daily for 3+ years. They failed and must pay for their consequences of the lives they have disrupted from getting a Breakthrough treatment for AD. FDA has always been on SAVÀs side and seen the good effects of treating/repairing misfolded protein. Cassava Sciences (NASDAQ:SAVA - Get Free Report) was upgraded by research analysts at HC Wainwright from a "neutral" rating to a "buy" rating in a report issued on Tuesday, MarketBeat.com reports. The brokerage currently has a $116.00 target price on the stock. HC Wainwright's price objective points to a potential upside of 356.51% from the company's current price.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
